MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Clinical trial NCT06191965 · RECRUITING

Trial details

NCT number: NCT06191965
Sponsor: Mclean Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia and Related Disorders Mitochondrial Alteration Cognitive Impairment

Start date: 2024-06-01
Primary completion: 2027-01-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.